Homozygosity for the Mediterranean <b>a</b>-thalassemic deletion (hemoglobin Barts hydrops fetalis)

• Main Authors: Al-Allawi Nasir, Shamdeen Maida, Rasheed Najeeb
• Format: Article
• Language: English
• Published: King Faisal Specialist Hospital and Research Centre 2010-01-01
• Series: Annals of Saudi Medicine
• Online Access: http://www.saudiannals.net/article.asp?issn=0256-4947;year=2010;volume=30;issue=2;spage=153;epage=155;aulast=Al-Allawi

Hemoglobin Barts hydrops fetalis syndrome is the most severe and generally fatal clinical phenotype of &#945;-thalassemia. We diagnosed a fetus at 23-weeks gestation with having hydrops fetalis, by ultrasound. At 32 weeks, intrauterine death was detected. Molecular studies revealed that the fetus had the hemoglobin Barts hydrops fetalis syndrome due to homozygosity for the Mediterranean &#945;-thalassemia deletion. This clinical phenotype is generally rare in the Eastern Mediterranean, and this is the first report of this syndrome from Iraq. Techniques for molecular characterization became available only very recently in this country, in a diagnostic setting. Thus, the detection of further cases might be expected in future.